SLQT
SelectQuote, Inc.
-0.00 (-0.75%)0.49USD120K成交股數86.9M市值–本益比(近四季)0.1股價營收比+5.6%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 322M-21% | 431M-10% | 537M+84% | 329M+7% | 408M+8% | 481M+19% | 292M+26% | 307M+3% | 376M | 405M | 233M | 299M |
| 營業成本 | 161M | 171M | 205M | 193M | 162M | 156M | 130M | 121M | 106M | 94.2M | 84.0M | 62.3M |
| 毛利 | 160M-35% | 260M-20% | 332M+104% | 136M-27% | 246M-9% | 325M+4% | 163M+9% | 187M-21% | 270M | 311M | 149M | 237M |
| 毛利率 | 49.8% | 60.3% | 61.8% | 41.4% | 60.2% | 67.5% | 55.7% | 60.7% | 71.8% | 76.8% | 63.9% | 79.2% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 36.1M | 38.2M | 38.9M | 35.8M | 41.7M | 45.0M | 36.1M | 44.0M | 35.0M | 33.4M | 28.7M | 27.5M |
| 營業利益 | 3.4M-84% | 35.9M-49% | 75.3M-729% | −40.7M+2829% | 22.1M-33% | 70.9M+28% | −12.0M-47% | −1.4M-104% | 33.1M | 55.3M | −22.4M | 33.7M |
| 營業利益率 | 1.1% | 8.3% | 14.0% | -12.4% | 5.4% | 14.7% | -4.1% | -0.5% | 8.8% | 13.6% | -9.6% | 11.3% |
| 稅後淨利 | −16.8M-165% | 40.2M-24% | 69.3M-256% | −30.5M-2% | 26.0M+204% | 53.2M+175% | −44.5M+43% | −31.0M-435% | 8.6M | 19.4M | −31.1M | 9.3M |
| 淨利率 | -5.2% | 9.3% | 12.9% | -9.3% | 6.4% | 11.1% | -15.2% | -10.1% | 2.3% | 4.8% | -13.3% | 3.1% |
| 稀釋 EPS | -0.17-667% | 0.11-63% | 0.26-200% | -0.26+53% | 0.03-40% | 0.30+173% | -0.26+37% | -0.17-383% | 0.05 | 0.11 | -0.19 | 0.06 |
| 稀釋股數 | 188M | 190M | 191M | 186M | 187M | 175M | 170M | 169M | 171M | 170M | 167M | 168M |
資產負債表 期末餘額
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 16.0M | 29.8M | 18.3M | 10.7M | 80.1M | 7.3M | 10.4M | 42.7M | 37.8M | 10.8M | 48.5M | 92.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | 8.8M | – | – | – | – |
| 總資產 | 1.3B | 1.3B | 1.4B | 1.2B | 1.3B | 1.3B | 1.1B | 1.2B | 1.2B | 1.2B | 1.2B | 1.3B |
| 有息負債 | 348M | 353M | 386M | 325M | 362M | 684M | 637M | 637M | 648M | 651M | 661M | 667M |
| 總負債 | 637M | 671M | 733M | 660M | 738M | 953M | 877M | 877M | 898M | 899M | 853M | 897M |
| 股東權益 | 352M | 385M | 360M | 305M | 350M | 326M | 269M | 317M | 347M | 337M | 317M | 391M |
| 負債比 | 49.5% | 50.3% | 54.2% | 54.7% | 57.0% | 74.5% | 76.5% | 73.5% | 72.1% | 72.8% | 72.9% | 69.6% |
| 淨現金(現金 − 有息負債) | −332M | −324M | −367M | −314M | −282M | −677M | −627M | −595M | −611M | −640M | −613M | −575M |
現金流量表 單季
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | −21.6M | – | – | −16.6M-30% | – | – | – | −23.7M | – |
| 資本支出 | – | – | – | 1.1M | – | – | 442K | – | – | – | 616K | – |
| 自由現金流 | – | – | – | −22.7M | – | – | −17.1M-30% | – | – | – | −24.3M | – |
| 折舊攤銷 | 4.5M | 4.4M | 4.3M | 4.3M | 4.9M | 5.1M | 5.6M | 6.4M | 6.7M | 5.9M | 6.0M | 7.1M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | -6.9% | – | – | -5.8% | – | – | – | -10.4% | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 1.6B
| Healthcare Services | 845M | 51.9% | +13.8% |
|---|---|---|---|
| Senior | 576M | 35.4% | -4.1% |
| Life | 186M | 11.4% | +7.6% |
| All Other Revenue | 20.2M | 1.2% | +12.2% |
產品／服務2026 年度 · 1.6B
| Pharmacy | 831M | 51.3% | +14.0% |
|---|---|---|---|
| 服務 | 788M | 48.7% | -1.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 1.6B | +6.0% | 62.2M | 3.8% | -0.06 | 27.6M |
| FY2025 | 1.5B | +15.5% | 47.6M | 3.1% | 0.01 | −13.9M |
| FY2024 | 1.3B | +31.8% | −34.1M | -2.6% | -0.20 | 11.9M |
| FY2023 | 1.0B | +31.3% | −58.5M | -5.8% | -0.35 | −20.8M |
| FY2022 | 764M | -17.8% | −298M | -38.9% | -1.81 | −363M |
| FY2021 | 930M | +75.7% | 125M | 13.4% | 0.75 | −130M |
| FY2020 | 529M | +56.9% | 79.5M | 15.0% | -0.18 | −71.2M |
| FY2019 | 337M | – | 72.6M | 21.5% | 0.55 | −3.8M |